UK markets close in 5 hours 40 minutes

CARGO Therapeutics, Inc. (CRGX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
20.38+0.14 (+0.69%)
At close: 04:00PM EDT
20.38 0.00 (0.00%)
After hours: 04:02PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 802.33M
Enterprise value 425.14M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)1.98
Enterprise value/revenue N/A
Enterprise value/EBITDA -4.58

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 338.73%
S&P500 52-week change 325.59%
52-week high 333.92
52-week low 313.14
50-day moving average 323.11
200-day moving average 321.12

Share statistics

Avg vol (3-month) 3313.23k
Avg vol (10-day) 3140.23k
Shares outstanding 539.37M
Implied shares outstanding 640.17M
Float 819.63M
% held by insiders 17.59%
% held by institutions 199.37%
Shares short (15 Apr 2024) 43.4M
Short ratio (15 Apr 2024) 47.77
Short % of float (15 Apr 2024) 410.28%
Short % of shares outstanding (15 Apr 2024) 48.63%
Shares short (prior month 15 Mar 2024) 42.2M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-26.09%
Return on equity (ttm)-53.03%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -95.22M
Net income avi to common (ttm)-98.15M
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)405.73M
Total cash per share (mrq)10.31
Total debt (mrq)28.54M
Total debt/equity (mrq)7.04%
Current ratio (mrq)19.35
Book value per share (mrq)N/A

Cash flow statement

Operating cash flow (ttm)-81.16M
Levered free cash flow (ttm)-68.1M